Contact Us

Congratulations: Beilu Pharma's Iohexol Injection Passed the Consistency Evaluation for Generic Drugs


Iohexol Contrast

Recently, Beijing Beilu Pharmaceutical Co., Ltd received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration (NMPA) on Iohexol Injection (100ml:35g, 100ml:30g), and the company's iohexol contrast passed the quality and efficacy consistency evaluation for generic drugs!

Related Products
Related News